What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Dr. Montalban debates on research in Multiple Sclerosis at TVE Dr. Xavier Montalban, head of clinical neuroimmunology group at Vall d'Hebron Research Institute (VHIR) and the Multiple Sclerosis Center of Catalonia (CEM-Cat) has participated in a discussion of multiple sclerosis at TVE in the show 'Para todos la 2'. They have also intervened Dr. Pablo Villoslada News VHIR participates in the official start of EATRIS to developing Europe's translational research of the future Today marks the official start of EATRIS, a pan-European network of translational research infrastructure in medicine. Building on a successful commencement phase funded by the European Commission in 2007-2010, Germany, Finland, Denmark, Italy, Spain and the Netherlands are parties to the new agree News The Princess of Asturias presents a cancer research grant from the AECC to Dr. Reventós Her Royal Highness the Princess of Asturias, Letizia Ortiz, permanently President of Honor of the Spanish Association Against Cancer (AECC) has presented the Cancer Research Grants awarded by the Science Foundation of the AECC in the institutional event that has taken place in Zaragoza. One of the g News Identified key mechanisms in the biology of tumor stem cells A team of researchers from Vall d'Hebron Research Institute (VHIR) has identified the mechanism used by cancer stem cells to protect against external attacks, the establishment of mechanisms of resistance and prevent differentiation to preserve its ability pluripotent, the ability to become any cell News VHIR participates in the III MTN Workshop On 27 and 28 September took place in one of the rooms of the FC Barcelona Camp Nou stadium the III MuscleTech Workshop, which aims to improve the quality of life for people with muscle diseases and reduce the number of sports injuries with improved tools for tendinopathies. The network, called 'Musc News VHIR's Heart Area at the World Heart Day The World Heart Day is an opportunity to increase the awareness of the population and of the administrations, politicians, productive sector and social agents of the enormous medical and economical burden of heart diseases in our society and in the world. A single heart disease, coronary artery dise News Members of the Russian Society of Ophthalmology attend a seminar by Dr. Simo at VHIR More than 50 members of the Russian Society of Ophthalmology attended on Thursday September 22 a seminar by Dr. Rafael Simó, head of diabetes and metabolism group of Vall d'Hebron Research Institute (VHIR) at he conference room of the hospital. The group, formed by the most prestigious Russian eye s News The Spanish Society of Probiotics and Prebiotics is created with leadership of VHIR’s researchers On September 21 was created the Spanish Society for Probiotics and Prebiotics (SEPyP), at Vall d’Hebron University Hospital, host of the new entity. The society will be chaired by Dr. Francisco Guarner, and in its board also will be Dr. Fernando Azpiroz, member and responsable respectively of the di News VHIR achieves a high success rate in the call for ISCIII health research projects Vall d'Hebron Research Institute (VHIR) is the second Catalan biomedical center with more projects awarded in the call for health research projects in 2011 of the Instituto de Salud Carlos III (ISCIII). VHIR has been granted in 27 of its 55 projects presented, representing 49.09% of the success rate News Dr. Boada at World Alzheimer's Day Coinciding with World Alzheimer's Day, Dr. Mercè Boada, head of the group of Alzheimer at Vall d'Hebron Research Institute (VHIR) and director of the ACE Foundation has participated in the program 'Els Matins' of TV3, and has been interviewed for various stories in other media. In addition, Dr. Boad News Bisphenol A disrupts the development of ovules in vitro and may increase the risk of Down syndrome Researchers at the Universitat Autònoma of Barcelona in collaboration with the Department of Obstetrics and Fetal Tissue Bank from Vall d'Hebron University Hospital have analyzed the effects of Bisphenol A (BPA), a polymer widely used for the manufacture of plastics, crop ovaries in vitro. This work News VHIR Predoctoral Fellowships Programa d’ajuts predoctorals per a la formació de personal investigador del Vall d’Hebron Institut de RecercaObjecte: selecció de 4 candidats per realitzar treballs de recerca dins del camp de la recerca biomèdica bàsica, clínica, epidemiològica, així com en gestió i avaluació de serveis i tecnolog News VHIR's director meets with the Minister Garmendia as general secretary of COSCE Dr. Joan Comella, director of the Vall d'Hebron Research Institute (VHIR), met on the afternoon of September 12 the Minister of Science and Innovation, Cristina Garmendia, in his role of secretary general of the Confederation of Scientific Societies of Spain (COSCE), along with its president Carlos News Discovered a new mechanism that regulates priority cell signaling pathways Researchers at Vall d'Hebron Research Institute (VHIR) have discovered a new cellular signaling mechanism that had been unknown until this moment. It is the coordinated use of two languages that are used by the cell to send internal signals in a precise and targeted way. This mechanism does not repl News Dr. Pozo explains the latest advances in headache Coinciding with the World Headache Day, Dr. Patricia Pozo Rosich, leaders of research group in headache and neurological pain at Vall d'Hebron Research Institute (VHIR ) explains the latest research on this subject in the news on TVE. Three and a half million of the Spanish population suffers migrai News Poor control of blood sugar in diabetics explains the low activity of some defense cells A study of the Vall d'Hebron Research Institute (VHIR) has showed the relationship between low phagocytic activity of macrophages (the body's defense cells) and poor control of glucose in patients with type II diabetes. This finding may explain the increased susceptibility of diabetics to suffer all News Found a recurrent fusion protein in colorectal tumor A team of researchers from Vall d'Hebron University Hospital, coordinated by Dr. Josep Tabernero, Chief of Oncology, participates in the first sequencing of nine colorectal tumor genomes that have been compared with nine complete genomes of healthy tissue from the same patients. The results of the i News Discovered how works a key protein that could be target for new treatments for CLL A recent study of Vall d'Hebron Research Institute (VHIR) has shown the mechanism that explains why the presence of a protein -ZAP-70- determines the prognosis of chronic lymphocytic leukemia (the most common among adults in the western world) and has given its key role as a potential therapeutic ta News VHIR participates in Multiple sclerosis research that doubles number of genes associated with the disease Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of a very debilitating neurological disease. Many of the genes implicated in the study are relevant to the immune system, shedding light onto the immunological pathways that under News Dr. Comella and Dr. Comabella debate on research at Onda Cero radio Dr Joan Comella, director of Vall d'Hebron Research Institute (VHIR), and Dr. Manuel Comabella, member of the clinical neuroimmunology grup at VHIR and representing CEM-Cat, participated Monday night in a discussion on research in Catalonia that organized the program 'Pont Barcelona-Madrid' at Onda Pagination First page « Previous page ‹ … Page 152 Page 153 Current page 154 Page 155 Page 156 … Next page › Last page »
